Manhattan Associates
MANH
$137.85
+7.80%
Manhattan Associates Inc. is a leading provider of supply chain, inventory, and omnichannel operations software, serving over 1,200 retailers, wholesalers, manufacturers, and logistics providers globally. The company is a recognized market leader in its niche, known for its deep domain expertise and comprehensive suite of enterprise solutions that manage complex logistics and retail operations. The current investor narrative is focused on the company's transition to a cloud-based subscription model and its ability to maintain growth and profitability amidst a challenging macroeconomic environment, as evidenced by recent quarterly results showing modest revenue growth but a sequential decline from prior quarters.…
MANH
Manhattan Associates
$137.85
Investment Opinion: Should I buy MANH Today?
Rating: Hold. The core thesis is that while MANH possesses strong underlying fundamentals, the clear deterioration in revenue momentum and margin compression warrant caution, making the stock dead money until growth reaccelerates or the valuation becomes compellingly cheap.
Supporting evidence includes a reasonable forward PE of 21.5x, which is digestible for a software company, and exceptionally strong profitability metrics like a 69.9% ROE and robust free cash flow generation of $374 million TTM. However, these positives are counterbalanced by the alarming sequential revenue decline in Q4 and the 330 bps operating margin compression year-over-year. The stock's technical position, trading just 4.1% above its 52-week low, reflects this fundamental damage.
The thesis would upgrade to a Buy if revenue growth reaccelerates above 10% YoY on a sequential basis and operating margins stabilize above 25%. It would downgrade to a Sell if the stock breaks below $119 support on sustained volume, or if QoQ revenue declines continue for a second consecutive quarter. Relative to its own history (trailing PE down from 85.8x) the stock is fairly valued, but not yet undervalued enough to discount the clear operational headwinds.
Sign up to view all
MANH 12-Month Price Forecast
The outlook is one of high uncertainty centered on growth. The company's financial health is not in question, but its growth engine is sputtering. The base case of stabilization is most likely, but the wide gap between the bull and bear cases (targets from $105 to $210) highlights the binary nature of the investment. The stance would upgrade to bullish on concrete evidence of revenue reacceleration and margin stabilization for two consecutive quarters. It would turn bearish on a breakdown below the $119 support level on high volume, signaling a loss of investor confidence in the turnaround narrative.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Manhattan Associates's 12-month outlook, with a consensus price target around $179.21 and implied upside of +30.0% versus the current price.
Average Target
$179.21
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$110 - $179
Analyst target range
Analyst coverage for Manhattan Associates appears limited based on the provided data, with only 2 analysts providing estimates for future EPS and revenue, which is insufficient to derive a meaningful consensus price target or recommendation distribution. This limited coverage is atypical for a company of its market cap (~$10.5B) and may indicate it is under-followed by the broader sell-side community, potentially leading to higher volatility and less efficient price discovery. The available institutional ratings from early 2026 show a generally bullish bias, with firms like Barclays (Overweight), Stifel (Buy), and Citigroup (upgraded to Buy) expressing positive views, suggesting professional sentiment is constructive despite the stock's severe price decline.
Bulls vs Bears: MANH Investment Factors
The evidence presents a stark conflict between a fundamentally sound, profitable company and a stock in severe technical distress. The bear case currently holds stronger evidence, as the market is punishing the clear deceleration in revenue growth and margin compression, overshadowing MANH's strong cash flow and balance sheet. The single most important tension in the investment debate is whether the current 5.7% YoY revenue growth represents a temporary trough in the cloud transition cycle or the beginning of a sustained slowdown that invalidates its premium valuation. The resolution of this growth trajectory will determine if the stock's deep oversold condition is a trap or an opportunity.
Bullish
- Strong Free Cash Flow Generation: The company generates substantial free cash flow, with TTM FCF of $374.01 million. This provides a strong financial foundation for share repurchases, as evidenced by the $76.98 million in buybacks in Q4 2025, and internal funding for growth initiatives.
- Robust Profitability and Margins: MANH maintains high profitability with a gross margin of 54.41% and an operating margin of 24.8% in Q4 2025. Its Return on Equity (ROE) of 69.9% is exceptionally high, indicating efficient use of shareholder capital.
- Healthy Balance Sheet with Low Debt: The company has a conservative debt-to-equity ratio of 0.357 and a current ratio of 1.28. This low leverage provides significant financial flexibility and resilience in a challenging macro environment.
- Deeply Oversold Technical Position: The stock is down 33.22% over the past year and trades only 4.1% above its 52-week low of $119.06. This extreme technical weakness, with a max drawdown of -46.97%, suggests the market has priced in significant pessimism, potentially creating a value opportunity.
Bearish
- Severe Revenue Growth Deceleration: Q4 2025 revenue grew only 5.7% YoY, a significant slowdown from prior quarters. More concerning is the sequential decline from Q3's $275.80 million to Q4's $270.39 million, indicating potential demand softness.
- Compressing Operating Margins: Operating margins have declined from 28.1% in Q3 2024 to 24.8% in Q4 2025. This 330 basis point compression suggests rising cost pressures or increased investment spending that is not being offset by top-line growth.
- Elevated Valuation Despite Price Drop: The stock trades at a trailing PE of 47.6x and a forward PE of 21.5x. While the forward multiple is more reasonable, the high trailing PE reflects earnings pressure, and the PEG ratio of 21.2 suggests growth expectations are still priced at a significant premium.
- Extreme Relative Underperformance: MANH has dramatically underperformed the market, with a -54.2% relative strength vs. the S&P 500 over the past year. This severe divergence, coupled with a beta near 1.0, indicates the weakness is company-specific, not macro-driven.
MANH Technical Analysis
The prevailing price trend for Manhattan Associates is a pronounced downtrend, with the stock down 33.22% over the past year and currently trading at a price of $127.87, which is only 4.1% above its 52-week low of $119.06. This positioning near the lows of its 52-week range suggests the stock is deeply oversold and may present a value opportunity, though it also reflects significant fundamental and technical damage. Recent momentum shows a mixed picture, with a 0.37% gain over the last three months but a sharp -8.45% decline over the past month, indicating short-term selling pressure is reasserting itself and diverging from the tentative stabilization seen in the 3-month window. Key technical levels are clearly defined, with immediate support at the 52-week low of $119.06 and formidable resistance at the 52-week high of $247.22; a breakdown below support could trigger further capitulation, while a sustained move above the $150-160 area would be needed to signal a potential trend reversal. The stock's beta of 0.962 indicates its volatility is roughly in line with the broader market, suggesting its recent severe underperformance is driven by company-specific factors rather than systemic risk aversion.
Beta
0.96
0.96x market volatility
Max Drawdown
-47.0%
Largest decline past year
52-Week Range
$119-$247
Price range past year
Annual Return
-29.0%
Cumulative gain past year
| Period | MANH Return | S&P 500 |
|---|---|---|
| 1m | -0.5% | -3.6% |
| 3m | +8.2% | +15.3% |
| 6m | -21.8% | +6.1% |
| 1y | -29.0% | +18.6% |
| ytd | -17.6% | +6.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MANH Fundamental Analysis
Manhattan Associates' revenue trajectory shows modest growth but recent deceleration; Q4 2025 revenue was $270.39 million, representing a 5.7% year-over-year increase, but this marks a sequential decline from Q3's $275.80 million and Q2's $272.42 million. The company's Cloud Subscriptions segment, at $108.56 million for the latest period, is a key growth driver, while the larger Service, Other segment ($120.01 million) provides a stable revenue base. The company is highly profitable, with Q4 2025 net income of $51.95 million and a robust gross margin of 54.41%, though operating margins have compressed slightly from the 28.1% seen in Q3 2024 to 24.8% in Q4 2025, indicating potential cost pressures or investment spending. Balance sheet and cash flow health is strong, characterized by a conservative debt-to-equity ratio of 0.357, a current ratio of 1.28, and substantial free cash flow generation, with TTM free cash flow of $374.01 million providing ample internal funding for growth and share repurchases, as evidenced by the $76.98 million in buybacks executed in Q4 2025.
Quarterly Revenue
$270389000.0B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.54%
Latest Quarter
Free Cash Flow
$374013000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MANH Overvalued?
Given Manhattan Associates' positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 47.61x and a forward PE of 21.48x, with the significant gap implying the market expects a substantial recovery in earnings growth over the next twelve months. Compared to industry averages (data not available in the provided set), a standalone assessment shows the forward PE of 21.5x appears reasonable for a profitable software company, but the elevated trailing PE reflects the compression in recent earnings. Historically, the stock's current trailing PE of 47.6x sits well below its own historical peaks, such as the 85.8x seen at the end of 2024, suggesting multiple compression has already occurred and the stock is trading at a more normalized, though not necessarily cheap, level relative to its own history.
PE
47.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 50x~119x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
35.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on growth sustainability and margin pressure. Revenue growth decelerated to 5.7% YoY in Q4 2025 and declined sequentially, raising concerns about demand for its supply chain software in a weaker macro environment. Concurrently, operating margins compressed by 330 basis points from their peak, indicating cost inflation or aggressive investment that may not yield immediate returns. The company's valuation remains elevated with a forward PE of 21.5x and a PEG ratio of 21.2, making it highly dependent on a reacceleration of earnings growth to justify its price.
Market & Competitive Risks are pronounced given the stock's severe underperformance. Trading 33% below its 52-week high and near its lows, the stock faces valuation compression risk if growth does not reaccelerate, as the market has shown little patience. Its beta of 0.962 suggests its woes are idiosyncratic, likely tied to concerns over its cloud transition pace and competitive pressures in the enterprise software space. The high short ratio of 4.64 reflects a crowded bearish bet that could lead to violent squeezes on positive news but also amplifies downside momentum on further disappointments.
The Worst-Case Scenario involves a continuation of the current trends: sequential revenue declines persist into 2026, operating margins compress further due to fixed costs on a smaller revenue base, and the market re-rates the stock from its forward PE of 21.5x to a more distressed multiple. This could see the stock break decisively below its key technical support at the 52-week low of $119.06. A realistic downside from the current price of $127.87 could be a further 20-25% decline, targeting the $95-$100 range, which would align with a forward PE in the mid-teens, a level more typical of a no-growth software business.
FAQ
The primary risk is sustained revenue deceleration, as seen in the sequential decline from Q3 to Q4 2025. Second is margin compression, with operating margins down 330 bps from their peak, threatening profitability. Third is valuation risk; the stock remains expensive on a PEG basis and could derate further if growth stalls. Fourth is sentiment risk, evidenced by extreme underperformance (-54% vs. SPY) and high short interest (short ratio 4.64), which can fuel exaggerated downside moves.
The 12-month forecast presents three scenarios. The base case (60% probability) sees the stock trading between $140 and $160 as growth stabilizes. The bull case (25% probability) targets $185-$210 on successful growth reacceleration. The bear case (15% probability) warns of a drop to $105-$120 if operational deterioration continues. The base case is most likely, hinging on the assumption that the current ~6% revenue growth rate is the new normal, not a prelude to a decline. The wide target ranges reflect high uncertainty.
MANH is fairly valued relative to its current growth profile but appears undervalued relative to its historical profitability. The trailing PE of 47.6x is elevated, reflecting compressed earnings, but the forward PE of 21.5x is reasonable for a profitable software company. However, the PEG ratio of 21.2 indicates the market is still pricing in significant future growth that recent quarterly results (5.7% YoY revenue increase) have not supported. The valuation implies the market expects a growth recovery; if that fails to materialize, the stock is overvalued.
MANH is a high-risk, potentially high-reward stock that is not a good buy for most investors at this moment. For aggressive investors with a long-term horizon, the current price near 52-week lows and strong underlying cash flow could represent a contrarian opportunity, but this is predicated on a belief that the company's revenue growth will reaccelerate. The 21.5x forward PE is not cheap enough to provide a significant margin of safety if growth continues to slow. It is best suited for patient, specialized investors willing to closely monitor quarterly execution.
MANH is unsuitable for short-term trading due to its high volatility, negative momentum, and company-specific uncertainty. It is a candidate only for long-term investment (minimum 2-3 year horizon) for investors who believe in the long-term necessity of its supply chain software and its ability to navigate the cloud transition. The stock's beta of 0.962 and lack of a dividend offer no short-term income or stability. The investment thesis requires time for operational improvements to manifest in financial results and for market sentiment to potentially reverse.